U.S. Small Molecule Innovator Cdmo Market Size & Outlook
U.S. small molecule innovator cdmo market, 2018-2030 (US$M)
Related Markets
U.S. small molecule innovator cdmo market highlights
- The U.S. small molecule innovator cdmo market generated a revenue of USD 12,205.9 million in 2023 and is expected to reach USD 18,194.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 5.9% from 2024 to 2030.
- In terms of segment, small molecule api was the largest revenue generating product in 2023.
- Small Molecule API is the most lucrative product segment registering the fastest growth during the forecast period.
Small molecule innovator cdmo market data book summary
| Market revenue in 2023 | USD 12,205.9 million |
| Market revenue in 2030 | USD 18,194.5 million |
| Growth rate | 5.9% (CAGR from 2023 to 2030) |
| Largest segment | Small molecule api |
| Fastest growing segment | Small Molecule API |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule API, Small Molecule Drug Product |
| Key market players worldwide | Wuxi AppTec Co Ltd, EQT Corp, Thermo Fisher Scientific Inc, Lonza Group Ltd, Catalent Inc, Siegfried Holding AG, Boehringer Ingelheim, Labcorp Holdings Inc, Piramal Pharma Solutions, CordenPharma, Cambrex |
Other key industry trends
- In terms of revenue, U.S. accounted for 25.1% of the global small molecule innovator cdmo market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. small molecule innovator cdmo market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 18,194.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Small Molecule Innovator CDMO Market Scope
Small Molecule Innovator CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. small molecule innovator cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to small molecule innovator cdmo market will help companies and investors design strategic landscapes.
Small molecule api was the largest segment with a revenue share of 61.64% in 2023. Horizon Databook has segmented the U.S. small molecule innovator cdmo market based on small molecule api, small molecule drug product covering the revenue growth of each sub-segment from 2018 to 2030.
Pharmaceutical companies are increasingly using CDMOs to manage their development and manufacturing tasks to scale costs, decrease time to market, and gain access to specialized expertise. CDMOs are growing to accommodate the increasing demand for outsourcing services.
Investments in new facilities, equipment upgrades, and process enhancements are all part of this expansion. These factors are driving the market growth in the U.S. Moreover, more businesses are expanding their manufacturing facilities to meet the growing demand for pharmaceuticals, which is contributing to market growth.
An increasing number of clinical trials are being conducted in the nation as a result of strong R&D practices and the promotion of novel therapies, which is further expected to create opportunities for CDMOs.
Reasons to subscribe to U.S. small molecule innovator cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. small molecule innovator cdmo market databook
-
Our clientele includes a mix of small molecule innovator cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. small molecule innovator cdmo market , including forecasts for subscribers. This country databook contains high-level insights into U.S. small molecule innovator cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. small molecule innovator cdmo market size, by product, 2018-2030 (US$M)
U.S. Small Molecule Innovator CDMO Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
